These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 12665661)

  • 21. Glycation in diabetic neuropathy: characteristics, consequences, causes, and therapeutic options.
    Thornalley PJ
    Int Rev Neurobiol; 2002; 50():37-57. PubMed ID: 12198817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycation, oxidation, and lipoxidation in the development of diabetic complications.
    Kennedy AL; Lyons TJ
    Metabolism; 1997 Dec; 46(12 Suppl 1):14-21. PubMed ID: 9439553
    [No Abstract]   [Full Text] [Related]  

  • 23. Pathologic role of dietary advanced glycation end products in cardiometabolic disorders, and therapeutic intervention.
    Yamagishi S; Matsui T
    Nutrition; 2016 Feb; 32(2):157-65. PubMed ID: 26602289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Advanced glycation end products (AGEs), free radicals and diabetes].
    Gillery P
    J Soc Biol; 2001; 195(4):387-90. PubMed ID: 11938555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Copper deficiency and cardiovascular disease: role of peroxidation, glycation, and nitration.
    Saari JT
    Can J Physiol Pharmacol; 2000 Oct; 78(10):848-55. PubMed ID: 11077985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phytochemicals Against Advanced Glycation End Products (AGEs) and the Receptor System.
    Yamagishi SI; Matsui T; Ishibashi Y; Isami F; Abe Y; Sakaguchi T; Higashimoto Y
    Curr Pharm Des; 2017; 23(8):1135-1141. PubMed ID: 27774900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ADP-ribose in glycation and glycoxidation reactions.
    Jacobson EL; Cervantes-Laurean D; Jacobson MK
    Adv Exp Med Biol; 1997; 419():371-9. PubMed ID: 9193679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of chronic aminoguanidine treatment on age-related glycation, glycoxidation, and collagen cross-linking in the Fischer 344 rat.
    Sell DR; Nelson JF; Monnier VM
    J Gerontol A Biol Sci Med Sci; 2001 Sep; 56(9):B405-11. PubMed ID: 11524442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycoxidation in aortic collagen from STZ-induced diabetic rats and its relevance to vascular damage.
    Meng J; Sakata N; Takebayashi S; Asano T; Futata T; Nagai R; Ikeda K; Horiuchi S; Myint T; Taniguchi N
    Atherosclerosis; 1998 Feb; 136(2):355-65. PubMed ID: 9543107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Role of Nonenzymatic Post-translational Protein Modifications in Uremic Vascular Calcification.
    Lim K; Kalim S
    Adv Chronic Kidney Dis; 2019 Nov; 26(6):427-436. PubMed ID: 31831121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting advanced glycation endproducts and mitochondrial dysfunction in cardiovascular disease.
    Ward MS; Fortheringham AK; Cooper ME; Forbes JM
    Curr Opin Pharmacol; 2013 Aug; 13(4):654-61. PubMed ID: 23871446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA-aptamers raised against AGEs as a blocker of various aging-related disorders.
    Yamagishi S; Taguchi K; Fukami K
    Glycoconj J; 2016 Aug; 33(4):683-90. PubMed ID: 27338620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidative stress, AGE, and atherosclerosis.
    Schleicher E; Friess U
    Kidney Int Suppl; 2007 Aug; (106):S17-26. PubMed ID: 17653206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bone metabolism and cardiovascular function update. Impairment of osteo-vascular interaction by glyco-oxidative stress].
    Yamagishi SI
    Clin Calcium; 2014 Jul; 24(7):85-91. PubMed ID: 24976060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of oxidative stress and NF-kappaB activation in late diabetic complications.
    Mohamed AK; Bierhaus A; Schiekofer S; Tritschler H; Ziegler R; Nawroth PP
    Biofactors; 1999; 10(2-3):157-67. PubMed ID: 10609877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Smooth muscle cell pathophysiology and advanced glycation end products (AGEs).
    Yamagishi S; Matsui T
    Curr Drug Targets; 2010 Jul; 11(7):875-81. PubMed ID: 20412043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease.
    Castellani R; Smith MA; Richey PL; Perry G
    Brain Res; 1996 Oct; 737(1-2):195-200. PubMed ID: 8930366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advanced glycation end products (AGEs) and their involvement in liver disease.
    Hyogo H; Yamagishi S
    Curr Pharm Des; 2008; 14(10):969-72. PubMed ID: 18473847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Active glycation in neurofibrillary pathology of Alzheimer disease: N(epsilon)-(carboxymethyl) lysine and hexitol-lysine.
    Castellani RJ; Harris PL; Sayre LM; Fujii J; Taniguchi N; Vitek MP; Founds H; Atwood CS; Perry G; Smith MA
    Free Radic Biol Med; 2001 Jul; 31(2):175-80. PubMed ID: 11440829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipid advanced glycosylation: pathway for lipid oxidation in vivo.
    Bucala R; Makita Z; Koschinsky T; Cerami A; Vlassara H
    Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6434-8. PubMed ID: 8341651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.